Novel series of CB2 selective antagonists for the treatment of autoimmune disorders: Synthesis, functional evaluation and ligand-steered modeling

被引:0
|
作者
Phatak, Sharangdhar S.
Petrov, Ravil R.
Astruc-Diaz, Fanny
Cavasotto, Claudio N.
Diaz, Philippe
机构
[1] Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX USA
[2] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
111-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
    Gado, Francesca
    Ferrisi, Rebecca
    Di Somma, Sarah
    Napolitano, Fabiana
    Mohamed, Kawthar A.
    Stevenson, Lesley A.
    Rapposelli, Simona
    Saccomanni, Giuseppe
    Portella, Giuseppe
    Pertwee, Roger G.
    Laprairie, Robert B.
    Malfitano, Anna Maria
    Manera, Clementina
    MOLECULES, 2022, 27 (09):
  • [22] Synthesis, molecular modeling and SAR. study of novel pyrazolo[5,1-f] [1,6]naphthyridines as CB2 receptor antagonists/inverse agonists
    Dore, Antonio
    Asproni, Battistina
    Scampuddu, Alessia
    Gessi, Stefania
    Murineddu, Gabriele
    Cichero, Elena
    Fossa, Paola
    Merighi, Stefania
    Bencivenni, Serena
    Pinna, Gerard A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5291 - 5301
  • [23] Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain
    Hollinshead, Sean P.
    Tidwell, Michael W.
    Palmer, John
    Guidetti, Rossella
    Sanderson, Adam
    Johnson, Michael P.
    Chambers, Mark G.
    Oskins, Jennifer
    Stratford, Robert
    Astles, Peter C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5722 - 5733
  • [24] Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction
    Tonelli, Michele
    Cichero, Elena
    Mahmoud, Ali Mokhtar
    Rabbito, Alessandro
    Tasso, Bruno
    Fossa, Paola
    Ligresti, Alessia
    MEDCHEMCOMM, 2018, 9 (12) : 2045 - 2054
  • [25] Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity
    Kikuchi, Akira
    Ohashi, Katsuyo
    Sugie, Yutaka
    Sugimoto, Hiromi
    Omura, Hirofumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 (02) : 219 - 224
  • [26] Fenchone Derivatives as a Novel Class of CB2 Selective Ligands: Design, Synthesis, X-ray Structure and Therapeutic Potential
    Smoum, Reem
    Haj, Christeene
    Hirsch, Shira
    Nemirovski, Alina
    Yekhtin, Zhannah
    Bogoslavsky, Benny
    Bakshi, Gaganjyot Kaur
    Chourasia, Mukesh
    Gallily, Ruth
    Tam, Joseph
    Mechoulam, Raphael
    MOLECULES, 2022, 27 (04):
  • [27] Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists
    Cheng, Yuan
    Albrech, Brian K.
    Brown, James
    Buchanan, John L.
    Buckner, William H.
    DiMauro, Erin F.
    Emkey, Renee
    Fremeau, Robert T., Jr.
    Harrnange, Jean-Christophe
    Hoffman, Beth J.
    Huang, Liyue
    Huang, Ming
    Lee, Josie Han
    Lin, Fen-Fen
    Martin, Matthew W.
    Nguyen, Hung Q.
    Patel, Vinod F.
    Tomlinson, Susan A.
    White, Ryan D.
    Xia, Xiaoyang
    Hitchcock, Stephen A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 5019 - 5034
  • [28] Design, synthesis and biological evaluation of novel biphenylsulfonamide derivatives as selective AT2 receptor antagonists
    Wang, Danhui
    Zhao, Wenjie
    Zhang, Zuzhi
    Zhang, Yanchun
    Li, Jiaming
    Huang, Weijun
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [29] Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease
    Mugnaini, Claudia
    Rabbito, Alessandro
    Brizzi, Antonella
    Palombi, Nastasja
    Petrosino, Stefania
    Verde, Roberta
    Di Marzo, Vincenzo
    Ligresti, Alessia
    Corelli, Federico
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 161 : 239 - 251
  • [30] 4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands: Structural Insights into the Design of a Novel Inverse Agonist Series
    El Bakali, Jamal
    Muccioli, Giulio G.
    Renault, Nicolas
    Pradal, Delphine
    Body-Malapel, Mathilde
    Djouina, Madjid
    Hamtiaux, Laurie
    Andrzejak, Virginie
    Desreumaux, Pierre
    Chavatte, Philippe
    Lambert, Didier M.
    Millet, Regis
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 7918 - 7931